Silicon-containing nanocarriers for targeted drug delivery: synthesis, physicochemical properties and acute toxicity

References

• Abdelkader H, Alani AW, Alany RG. (2014). Recent advances in non-ionic surfactantvesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv 21:87–100
   PubMed Web of Science ®Google Scholar
• Bae YH. (2009). Drug targeting and tumor heterogeneity. J Control Release 133:2–3
   PubMed Web of Science ®Google Scholar
• Barandeh F, Nguyen PL, Kumar R, et al. (2012). Organically modified silica nanoparticles are biocompatible and can be targeted to neurons in vivo. PLoS One 7:e29424
   PubMed Web of Science ®Google Scholar
• Bharali DJ, Klejbor I, Stachowiak EK, et al. (2005). Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. Proc Natl Acad Sci USA 102:11539–44
   PubMed Web of Science ®Google Scholar
• Cai D, Mataraza JM, Qin ZH, et al. (2005). Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing. Nat Methods 2:449–54
   PubMed Web of Science ®Google Scholar
• Chittasupho C, Jaturanpinyo M, Mangmool S. (2013). Pectin nanoparticle enhances cytotoxicity of methotrexate against HepG2 cells. Drug Deliv 20:1–9
   PubMed Web of Science ®Google Scholar
• De Jong WH, Borm PJ. (2008). Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 3:133–49
   PubMed Web of Science ®Google Scholar
• Foldvari M, Bagonluri M. (2008). Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues. Nanomedicine 4:183–200
   PubMed Web of Science ®Google Scholar
• Galagudza MM, Korolev DV, Sonin DL, et al. (2010a). Passive targeting of ischemic myocardium with the use of silica nanoparticles. Nanotechnol Russia 5:844–50
   Google Scholar
• Galagudza M, Korolev D, Sonin D, et al. (2010b). Targeted drug delivery to ischemic heart with use of nanoparticulate carriers: concepts, pitfalls and perspectives. J Manuf Technol Manage 21:930–49
   Google Scholar
• Galagudza M, Korolev D, Postnov V, et al. (2012). Passive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticles. Int J Nanomed 7:1671–8
   PubMed Web of Science ®Google Scholar
• Gunawardena S. (2012). Developing nanotherapies for neurodegenerative diseases: ORMOSIL and its potential in axonal transport. Ther Deliv 3:1189–98
   PubMedGoogle Scholar
• Headrick JP, Lasley RD. (2009). Adenosine receptors and reperfusion injury of the heart. Handb Exp Pharmacol 193:189–214
   PubMedGoogle Scholar
• Ivanov S, Zhuravsky S, Yukina G, et al. (2012). In vivo toxicity of intravenously administered silica and silicon nanoparticles. Materials 5:1873–89
   Web of Science ®Google Scholar
• Jacobson KA. (2009). Introduction to adenosine receptors as therapeutic targets. Handb Exp Pharmacol 193:1–24
   PubMedGoogle Scholar
• Klejbor I, Stachowiak EK, Bharali DJ, et al. (2007). ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology. J Neurosci Methods 165:230–43
   PubMed Web of Science ®Google Scholar
• Kumar R, Roy I, Ohulchanskyy TY, et al. (2008). Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. ACS Nano 2:449–56
   PubMed Web of Science ®Google Scholar
• Kumar R, Roy I, Ohulchanskkyy TY, et al. (2010). In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 4:699–708
   PubMed Web of Science ®Google Scholar
• Lyseng-Williamson KA, Duggan ST, Keating GM. (2013). Pegylated liposomal doxorubicin: a guide to its use in various malignancies. BioDrugs 27:533–40
   PubMed Web of Science ®Google Scholar
• Li M, Wang G, Li H, et al. (2015). How to deliver therapeutics or imaging agents to the infracted heart? Austin Therapeutics 2:1013
   Google Scholar
• Liu YL, Hsu CY, Su YH, et al. (2005). Chitosan-silica complex membranes from sulfonic acid functionalized silica nanoparticles for pervaporation dehydration of ethanol-water solutions. Biomacromolecules 6:368–73
   PubMed Web of Science ®Google Scholar
• Levchenko TS, Hartner WC, Torchilin VP. (2012). Liposomes in diagnosis and treatment of cardiovascular disorders. Method Debakey Cardiovasc J 8:36–41
   PubMedGoogle Scholar
• Malvindi MA, Brunetti V, Vecchio G, et al. (2012). SiO2 nanoparticles biocompatibility and their potential for gene delivery and silencing. Nanoscale 4:486–95
   PubMed Web of Science ®Google Scholar
• Nishimori H, Kondoh M, Isoda K, et al. (2009). Silica nanoparticles as hepatotoxicants. Eur J Pharm Biopharm 72:496–501
   PubMed Web of Science ®Google Scholar
• Osek J. (2003). Detection of the enteroaggregative Escherichia coli heat stable enterotoxin 1 (EAST1) gene and its relationship with fimbrial and enterotoxin markers in E. coli isolates from pigs with diarrhea. Vet Microbiol 91:65–72
   PubMed Web of Science ®Google Scholar
• Puntawee S, Theerasilp M, Reabroi S, et al. (2015). Solubility enhancement and in vitro evaluation of PEG-b-PLA micelles as nanocarrier of semi-synthetic andrographolide analogue for cholangiocarcinoma chemotherapy. Pharm Dev Technol. [Epub ahead of print]. doi: 10.3109/10837450.2015.1016619
   PubMed Web of Science ®Google Scholar
• Roy I. (2012). Synthesis, surface modification, characterization, and biomedical in vitro applications of organically modified silica (ORMOSIL) nanoparticles. Methods Mol Biol 906:365–79
   PubMedGoogle Scholar
• Rasouli S, Davaran S, Rasouli F, et al. (2014). Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery. Drug Deliv 21:155–63
   PubMed Web of Science ®Google Scholar
• Selvestrel F, Moret F, Segat D, et al. (2013). Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems. Nanoscale 5:6106–16
   PubMed Web of Science ®Google Scholar
• Singh SP, Sharma M, Patel H, et al. (2014). Extra cellular pH influences uptake and photodynamic action of pyropheophorbide-a entrapped in folate receptor targeted organically modified silica nanoparticle. Photodiagn Photodyn Ther 11:156–64
   PubMed Web of Science ®Google Scholar
• Takahama H, Minamino T, Asanuma H, et al. (2009). Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats. J Am Coll Cardiol 53:709–17
   PubMed Web of Science ®Google Scholar
• Xie G, Sun J, Zhong G, et al. (2010). Biodistribution and toxicity of intravenously administered silica nanoparticles in mice. Arch Toxicol 84:183–90
   PubMed Web of Science ®Google Scholar
• Zhou L, Yuan J, Yuan W, et al. (2009). Synthesis and characterization of multi-functional hybrid magnetite nanoparticles with biodegradability, superparamagnetism, and fluorescence. Mater Lett 63:1567–70
   Web of Science ®Google Scholar